Literature DB >> 8898836

Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.

R T Burks1, M E Sherman, R J Kurman.   

Abstract

According to the International Federation of Gynecology and Obstetrics (FIGO) and the World Health Organization (WHO), stromal invasion, defined as destructive infiltrative growth, is the sole criterion used to distinguish serous borderline tumors from invasive serous carcinomas of the ovary. Although this criterion effectively identifies most malignant tumors, it does not permit the identification of a small subset of well-differentiated ovarian carcinomas that do not display destructive infiltrative growth but that may be associated with malignant behavior. In this study, we describe a group of such serous neoplasms that have distinctive morphologic features and that are often associated with progressive, invasive disease. We have designated these tumors micropapillary serous carcinomas (MPSC). They are characterized by a filigree pattern of highly complex micropapillae arising directly from large, bulbous papillary structures. The micropapillae are covered by round to cuboidal cells with a high nuclear-to-cytoplasmic ratio. Typical serous borderline tumors tend to display a hierarchical pattern of branching terminating in small papillae or tufts, and the cells covering the papillae tend to be more columnar and often ciliated compared with cells of MPSC. We reviewed more than 400 cases of serous ovarian borderline tumors and well-differentiated serous carcinomas and identified 26 cases of MPSC. Seventeen tumors lacked destructive infiltrative growth (noninvasive), and nine contained areas of invasion ranging from minimal to extensive. Eight of the 26 tumors were stage I, and none of the patients developed recurrence whether or not their tumors had demonstrable invasion. In contrast, of the 16 women presenting with stage II disease or higher and who had more than 1 year of follow-up, eight (50%) have either died of intra-abdominal carcinomatosis or are alive with carcinoma. Twenty-four (92%) of MPSCs contained areas of serous borderline tumor. The frequent association of MPSCs with serous borderline tumors suggests that MPSCs arise from the latter and may account for the few cases of serous borderline tumors that have been associated with progression to invasive carcinoma.

Entities:  

Mesh:

Year:  1996        PMID: 8898836     DOI: 10.1097/00000478-199611000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  45 in total

1.  Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.

Authors:  Catherine Uzan; Aminata Kane; Annie Rey; Sebastien Gouy; Sophie Camatte; Patricia Pautier; Catherine Lhommé; Christine Haie-Meder; Pierre Duvillard; Philippe Morice
Journal:  Oncologist       Date:  2011-01-27

2.  Stromal micropapillary pattern predominant lung adenocarcinoma--a report of two cases.

Authors:  Miki Ohe; Tomoyuki Yokose; Yuji Sakuma; Sachie Osanai; Chikako Hasegawa; Kota Washimi; Kimitoshi Nawa; Tetsukan Woo; Rurika Hamanaka; Haruhiko Nakayama; Yoichi Kameda; Kouzo Yamada; Takeshi Isobe
Journal:  Diagn Pathol       Date:  2011-09-29       Impact factor: 2.644

Review 3.  Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems.

Authors:  Russell Vang; Ie-Ming Shih; Robert J Kurman
Journal:  Adv Anat Pathol       Date:  2009-09       Impact factor: 3.875

4.  Micropapillary pattern in newly diagnosed borderline tumors of the ovary: what's in a name?

Authors:  Mario M Leitao
Journal:  Oncologist       Date:  2011-01-27

5.  Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis.

Authors:  Qingfu Zhang; Jian Ming; Siyang Zhang; Bo Li; Liying Yin; Xueshan Qiu
Journal:  Gastric Cancer       Date:  2014-02-22       Impact factor: 7.370

6.  Adhering to the 2014 WHO terminology on borderline ovarian tumors.

Authors:  Jaime Prat
Journal:  Virchows Arch       Date:  2017-02       Impact factor: 4.064

Review 7.  [Pitfalls and common problems in the differential diagnosis of epithelial ovarian tumors].

Authors:  S F Lax
Journal:  Pathologe       Date:  2019-02       Impact factor: 1.011

Review 8.  Management, prognosis and reproductive outcomes of borderline ovarian tumor relapse during pregnancy: from diagnosis to potential treatment options.

Authors:  Francesco Cosentino; Luigi Carlo Turco; Stefano Cianci; Francesco Fanfani; Anna Fagotti; Salvatore Gueli Alletti; Giuseppe Vizzielli; Salvatore Giovanni Vitale; Antonio Simone Laganà; Francesco Padula; Claudio Coco; Salvatore Pisconti; Giovanni Scambia
Journal:  J Prenat Med       Date:  2016 Jan-Jun

Review 9.  Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors.

Authors:  S Avril
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

Review 10.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

Authors:  Ie-Ming Shih; Robert J Kurman
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.